Galmed Pharmaceuticals Stock Investor Sentiment

GLMD Stock  USD 2.30  0.31  11.88%   
About 61% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Galmed Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  

Galmed Pharmaceuticals Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Galmed Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
54.7%
55.2%
58.5%
56.3%
57.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at finance.yahoo.com         
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai
Yahoo News
over a year ago at thelincolnianonline.com         
Short Interest in Galmed Pharmaceuticals Ltd. Drops By 28.5
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Earns Sell Rating from Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Coverage Initiated at StockNews.com
news
over a year ago at finance.yahoo.com         
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, ...
Yahoo News
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Ltd. Given Consensus Recommendation of Hold by Brokerages
news
over a year ago at news.google.com         
Protagenic Therapeutics says board approved 1-for-4 reverse stock ... - Seeking Alpha
Google News at Macroaxis
over a year ago at kalkinemedia.com         
Galmed Pharmaceuticals Ltd expected to post a loss of15cents a share - Earnings Preview
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Ltd. Given Average Recommendation of Hold by Analysts
news
over a year ago at news.google.com         
Galmed Pharmaceuticals Ltd. Stock Price Today, Quote ... - Seeking Alpha
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals to Release Quarterly Earnings on Monday
news
over a year ago at thefly.com         
Galmed awarded patent for Aramchol meglumine salt by USPTO
news
over a year ago at finance.yahoo.com         
Galmed Announces Issuance of New Composition of Matter Patent for Aramchol meglumine Salt
Yahoo News
over a year ago at news.google.com         
Baharaff Allen Increases Position in Galmed Pharmaceuticals - Nasdaq
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by StockNews.com
news
Far too much social signal, news, headlines, and media speculation about Galmed Pharmaceuticals that are available to investors today. That information is available publicly through Galmed media outlets and privately through word of mouth or via Galmed internal channels. However, regardless of the origin, that massive amount of Galmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Galmed Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Galmed Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Galmed Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Galmed Pharmaceuticals alpha.

Galmed Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15Galmed Pharmaceuticals Galmed Pharmaceuticals Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories